Amanote Research
Register
Sign In
Bone Safety Profile of Denosumab Therapy: A Pharmacovigilance Characterization Analysis
Value in Health
- United Kingdom
doi 10.1016/j.jval.2015.03.1098
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2015
Authors
A.K. Ali
Publisher
Elsevier BV
Related search
Denosumab for Bone Diseases: Translating Bone Biology Into Targeted Therapy
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Significant Improvement of Bone Mineral Density and Bone Turnover Markers by Denosumab Therapy in Bisphosphonate-Unresponsive Patients
Osteoporosis International
Medicine
Endocrinology
Metabolism
Diabetes
Pharmacovigilance; A Paradigm Shift From Care to Safety
THE PROFESSIONAL MEDICAL JOURNAL
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
FRI0561 Safety of Denosumab in Post-Menopausal Osteoporosis and in Cancer: A Systematic Review and Meta-Analysis
A Recurrent Giant Cell Tumor of Bone Treated With Denosumab: A Case Report
Clinics and Practice
Pharmacotherapy of Bone Loss in Postmenopausal Women: Focus on Denosumab
Clinical Medicine. Therapeutics
Efficacy and Safety Profile of Xanthines in COPD: A Network Meta-Analysis
European Respiratory Review
Pulmonary
Respiratory Medicine
Giant-Cell Tumor of Bone: Treatment Options and Role of Denosumab
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
